glp-1 meds corona Medscape | receptor agonists such as semaglutide are changing the way type 2 diabetes and obesity are treated. But these drugs have also shown a Staying in Scope: Understanding COVID-19

Even with powerful injectable therapies, there remains a group of patients for whom bariatric surgery is still the stronger long-term answer

Aetna also considers nutritional counseling medically necessary for managing chronic conditions such as diabetes, hypertension, kidney disease, eating disorders, and more

Curr Pharm Des 10 : 36833695 Cellek S et al

Evidence from previous studies show that weight loss can significantly reduce the risk of obesity-related complications and chronic diseases

In the meantime, people taking GLP-1 agonists for weight loss may need to lean on old fashioned methods for retaining muscle exercise and a healthy diet and there are groups trying to make this easier